Skip to Main Content

Author Details

Darran P O'Connor
UCD Conway Institute, University College Dublin
2001
68
32
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35332319Author Correction: Antibody-based proteomics: fast-tracking molecular diagnostics in oncology.Nat Rev Cancer2022
35711675Master Transcription Regulators and Transcription Factors Regulate Immune-Associated Differences Between Patients of African and European Ancestry With Colorectal Cancer.Gastro Hep Adv2022
33122343Effects of HER Family-targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer.Clin Cancer Res2021
33523897Multiple screening approaches reveal HDAC6 as a novel regulator of glycolytic metabolism in triple-negative breast cancer.Sci Adv2021
34090143Prognostic value of the 6-gene OncoMasTR test in hormone receptor-positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors.Eur J Cancer2021
33955407An Insight Into the Driver Mutations and Molecular Mechanisms Underlying Mucinous Adenocarcinoma of the Rectum.Dis Colon Rectum2021
32555399Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer.Sci Rep2020
33004351A Functional Genomic Screen Identifies the Deubiquitinase USP11 as a Novel Transcriptional Regulator of ERα in Breast Cancer.Cancer Res2020
31139326Correction: BAG3 promotes tumour cell proliferation by regulating EGFR signal transduction pathways in triple negative breast cancer.Oncotarget2019
29961873Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable Targets.J Natl Cancer Inst2019
31409615BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer.Clin Cancer Res2019
30798618Targeted DNA Methylation Profiling of Human Cardiac Tissue Reveals Novel Epigenetic Traits and Gene Deregulation Across Different Heart Failure Patient Subtypes.Circ Heart Fail2019
29069577Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007.Cancer Lett2018
30291241Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy.Nat Commun2018
29644001BAG3 promotes tumour cell proliferation by regulating EGFR signal transduction pathways in triple negative breast cancer.Oncotarget2018
29792754Loss of Chromosome 18q11.2-q12.1 Is Predictive for Survival in Patients With Metastatic Colorectal Cancer Treated With Bevacizumab.J Clin Oncol2018
29567811Epigenome-wide SRC-1-Mediated Gene Silencing Represses Cellular Differentiation in Advanced Breast Cancer.Clin Cancer Res2018
29243812Dysregulated mitogen-activated protein kinase signalling as an oncogenic basis for clear cell sarcoma of the kidney.J Pathol2018
27615392Mutant p53: a novel target for the treatment of patients with triple-negative breast cancer?Int J Cancer2017
32913965Postmortem Examination of an Aggressive Case of Medullary Thyroid Carcinoma Characterized by Catastrophic Genomic Abnormalities.JCO Precis Oncol2017
28487489Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancer.Oncotarget2017
28455421Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast Cancer.Cancer Res2017
28154183The Emerging Role of Non-traditional Ubiquitination in Oncogenic Pathways.J Biol Chem2017
28213567Vitamin D receptor as a target for breast cancer therapy.Endocr Relat Cancer2017
28554894Fam60a defines a variant Sin3a-Hdac complex in embryonic stem cells required for self-renewal.EMBO J2017
28611295Assessment of concordance between fresh-frozen and formalin-fixed paraffin embedded tumor DNA methylation using a targeted sequencing approach.Oncotarget2017
27796961Assessment of Significance of Novel Proteins in Breast Cancer Using Tissue Microarray Technology.Methods Mol Biol2017
26895288Diagnostic and Therapeutic Implications of Histone Epigenetic Modulators in Breast Cancer.Expert Rev Mol Diagn2016
27482648De novo post-diagnosis statin use, breast cancer-specific and overall mortality in women with stage I-III breast cancer.Br J Cancer2016
27354233Biosimilars: Extrapolation for oncology.Crit Rev Oncol Hematol2016
27377904RE: RNA Disruption Assay as a Biomarker of Pathological Complete Response in Neoadjuvant Trastuzumab-Treated Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.J Natl Cancer Inst2016
26729235Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.Sci Rep2016
25626736Monounsaturated fatty acid-enriched high-fat diets impede adipose NLRP3 inflammasome-mediated IL-1β secretion and insulin resistance despite obesity.Diabetes2015
25906750FKBPL: a marker of good prognosis in breast cancer.Oncotarget2015
24649821microRNAs: a new class of breast cancer biomarkers.Expert Rev Mol Diagn2014
25927669A novel mechanism of regulation of the anti-metastatic miR-31 by EMSY in breast cancer.Breast Cancer Res2014
25455730p53 as a target for the treatment of cancer.Cancer Treat Rev2014
25379014Dynamic and influential interaction of cancer cells with normal epithelial cells in 3D culture.Cancer Cell Int2014
25011585Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer.Breast Cancer Res2014
22740095Ghrelin concentrations in maternal and cord blood of type 1 diabetic and non-diabetic pregnancies at term.Endocrine2013
24204025miRNA dysregulation in breast cancer.Cancer Res2013
23359479Identification of transcription factors associated with castration-resistance: is the serum responsive factor a potential therapeutic target?Prostate2013
22139072The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ERα, and is an independent prognostic factor in node-negative breast cancer.Oncogene2012
22935204Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer.Diagn Pathol2012
23060431miR-187 is an independent prognostic factor in breast cancer and confers increased invasive potential in vitro.Clin Cancer Res2012
22332848Maternal and fetal cocaine- and amphetamine-regulated transcript in diabetic and non-diabetic pregnancy.Gynecol Endocrinol2012
21281480Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen.Breast Cancer Res2011
21999197Identification of a myometrial molecular profile for dystocic labor.BMC Pregnancy Childbirth2011
21982118Characterisation and manipulation of docetaxel resistant prostate cancer cell lines.Mol Cancer2011
21677534SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas.Am J Surg Pathol2011
  • 1 - 50 of 68

Recommended Authors

Juan Moreno
University of Toronto
Career Start Year 2011
Number of shared co-authors 0
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 1
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 0
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 1
Karolina Edlund
Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund
Career Start Year 2008
Number of shared co-authors 10
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 1
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 3
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 0
Nicola Fusco
IEO European Institute of Oncology IRCCS
Career Start Year 2002
Number of shared co-authors 1
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 1
Loris De Cecco
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year 2000
Number of shared co-authors 0
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 8
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 1
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 7
Cecilia Williams
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 5
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 1
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 1
Susan J Done
University Health Network
Career Start Year 1994
Number of shared co-authors 1
Paul N Span
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 4
Kornelia Polyak
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1991
Number of shared co-authors 4
Ben Ho Park
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 1
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 11
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 1
Laura J Van't Veer
University of California San Francisco
Career Start Year 1984
Number of shared co-authors 10
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 2
David L Rimm
Yale University School of Medicine
Career Start Year 1980
Number of shared co-authors 8
Christopher C Benz
Buck Institute for Research on Aging
Career Start Year 1977
Number of shared co-authors 2
Irene L Andrulis
University of Toronto
Career Start Year 1977
Number of shared co-authors 7
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 2

Collaborators

William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Co-authored papers 47
Karin Jirstr??m
Lund University
Co-authored papers 16
Donal J Brennan
National Centre for Peritoneal Malignancy, Mater Misericordiae University Hospital
Co-authored papers 16
Rut Klinger
UCD Conway Institute, University College Dublin
Co-authored papers 14
Elton Rexhepaj
UCD Conway Institute, University College Dublin
Co-authored papers 8
Sharon F McGee
The Ottawa Hospital Cancer Centre
Co-authored papers 7
Fredrik Pont??n
Uppsala University
Co-authored papers 7
Mathias Uhl??n
KTH Royal Institute of Technology
Co-authored papers 6
Bauke Ylstra
Cancer Center Amsterdam, Vrije Universiteit Amsterdam
Co-authored papers 6
Annette T Byrne
Royal College of Surgeons in Ireland (RCSI)
Co-authored papers 5
Diether Lambrechts
Co-authored papers 5
Timo Gaiser
Institut fur Pathologie, Universitatsmedizin Mannheim
Co-authored papers 5
Stephen R Pennington
UCD Conway Institute, University College Dublin
Co-authored papers 4
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 3
Robert C Millikan
Co-authored papers 3
Aedin C Culhane
Dana-Farber Cancer Institute & Harvard School of Public Health
Co-authored papers 3
Gillian O'Hurley
OncoMark Ltd
Co-authored papers 3
Eugene T Dillon
Conway Institute of Biomolecular and Biomedical Research
Co-authored papers 2
Gerard Cagney
Conway Institute of Biomedical and Biomolecular Sciences, University College Dublin
Co-authored papers 2
Carl A K Borrebaeck
Lund University
Co-authored papers 2
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Olli Kallioniemi
Karolinska Institute
Co-authored papers 2
Kieran Wynne
University College Dublin
Co-authored papers 2
Gerrit A Meijer
The Netherlands Cancer Institute
Co-authored papers 2
Oscar M Rueda
University of Cambridge
Co-authored papers 2
Patrick G Buckley
Beaumont Hospital
Co-authored papers 2
Karsten Hokamp
Smurfit Institute of Genetics, Trinity College of Dublin
Co-authored papers 2
Catherine M Kelly
Mater Misericordiae University Hospital
Co-authored papers 2
Sami Kilpinen
University of Helsinki
Co-authored papers 2
Adrian P Bracken
Smurfit Institute of Genetics, Trinity College Dublin
Co-authored papers 2
Release 1.2